Loading...
•
Jun 30, 2024
Pediatrix Q2 2024 Earnings Report
Pediatrix reported a net loss of $1.84 per share and an adjusted EPS of $0.34 for the second quarter of 2024.
Key Takeaways
Pediatrix Medical Group reported second-quarter results exceeding expectations with stable patient volumes, improved payor mix, and operating efficiencies. The company reported a net revenue of $504 million, a net loss of $153 million, and an adjusted EBITDA of $58 million.
Net revenue reached $504 million.
Net loss was reported at $153 million.
Adjusted EBITDA totaled $58 million.
Portfolio management plans are underway and expected to be completed by the end of 2024.
Forward Guidance
Pediatrix anticipates its 2024 Adjusted EBITDA to be in the range of $200 million to $220 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...